Celcuity Future Growth
Future criteria checks 2/6
Celcuity is forecast to grow earnings and revenue by 27.6% and 73.6% per annum respectively while EPS is expected to grow by 32.9% per annum.
Key information
27.6%
Earnings growth rate
32.9%
EPS growth rate
| Biotechs earnings growth | 28.3% |
| Revenue growth rate | 73.6% |
| Future return on equity | n/a |
| Analyst coverage | Good |
| Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts
Nov 06Is Celcuity (NASDAQ:CELC) Using Too Much Debt?
Aug 31
Celcuity: Flying A Phase 3 Trial Right Under Your Nose
Jul 05Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?
May 08Is Celcuity (NASDAQ:CELC) Using Too Much Debt?
Jul 04Is Celcuity (NASDAQ:CELC) A Risky Investment?
Sep 13Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment
Jul 18Is Celcuity (NASDAQ:CELC) A Risky Investment?
Jan 27Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?
Sep 21Celcuity: Nipping The Oncogenic Bud
Jul 08What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition
Mar 14We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely
Jan 20Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies
Dec 23Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?
Nov 29Celcuity EPS beats by $0.03
Nov 09Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 50 | -159 | -88 | -159 | 6 |
| 12/31/2025 | 1 | -144 | -94 | -131 | 7 |
| 12/31/2024 | N/A | -105 | -70 | -77 | 7 |
| 9/30/2024 | N/A | -94 | -74 | -74 | N/A |
| 6/30/2024 | N/A | -83 | -67 | -66 | N/A |
| 3/31/2024 | N/A | -73 | -58 | -58 | N/A |
| 12/31/2023 | N/A | -64 | -54 | -54 | N/A |
| 9/30/2023 | N/A | -57 | -45 | -45 | N/A |
| 6/30/2023 | N/A | -49 | -41 | -41 | N/A |
| 3/31/2023 | N/A | -45 | -43 | -43 | N/A |
| 12/31/2022 | N/A | -41 | -36 | -36 | N/A |
| 9/30/2022 | N/A | -36 | -33 | -33 | N/A |
| 6/30/2022 | N/A | -31 | -27 | -27 | N/A |
| 3/31/2022 | N/A | -35 | -24 | -24 | N/A |
| 12/31/2021 | N/A | -30 | -20 | -20 | N/A |
| 9/30/2021 | N/A | -25 | -16 | -16 | N/A |
| 6/30/2021 | N/A | -22 | -14 | -14 | N/A |
| 3/31/2021 | N/A | -10 | -8 | -8 | N/A |
| 12/31/2020 | N/A | -9 | -7 | -7 | N/A |
| 9/30/2020 | N/A | -9 | -7 | -7 | N/A |
| 6/30/2020 | N/A | -8 | -7 | -7 | N/A |
| 3/31/2020 | N/A | -8 | -7 | -6 | N/A |
| 12/31/2019 | N/A | -7 | -6 | -6 | N/A |
| 9/30/2019 | N/A | -7 | -6 | -6 | N/A |
| 6/30/2019 | N/A | -7 | -7 | -6 | N/A |
| 3/31/2019 | N/A | -7 | -7 | -6 | N/A |
| 12/31/2018 | N/A | -7 | -7 | -6 | N/A |
| 9/30/2018 | N/A | -7 | -6 | -6 | N/A |
| 6/30/2018 | N/A | -7 | N/A | -6 | N/A |
| 3/31/2018 | N/A | -7 | N/A | -5 | N/A |
| 12/31/2017 | N/A | -6 | N/A | -5 | N/A |
| 9/30/2017 | N/A | -5 | N/A | -5 | N/A |
| 6/30/2017 | N/A | -5 | N/A | -4 | N/A |
| 3/31/2017 | N/A | -4 | N/A | -3 | N/A |
| 12/31/2016 | N/A | -3 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CELC is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CELC is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CELC is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CELC's revenue (73.6% per year) is forecast to grow faster than the US market (8.9% per year).
High Growth Revenue: CELC's revenue (73.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CELC's Return on Equity is forecast to be high in 3 years time